Self-Management Training With Online Intervention Process for Young Adults With Chronic Conditions

Self-Management Training With Online Intervention Process for Young Adults With Chronic Conditions: Effects on Self-Management, Emotion Regulation, and Occupational Balance: A Randomized Controlled Study

The study was conducted from 15th April 2021 to 15th August 2021. It employed a pretest-posttest design with control and training groups. In this study, a pretest-posttest design including control and training groups was used. Pre-assessments were taken from young adults who reported that they wanted to participate in the study via social media accounts and e-mail and who met the study criteria, and two groups were formed by the simple randomization method. The study group received 8 weeks of self-management training. The control group was informed about self-management for 1 week. Final evaluations were conducted for both groups after eight weeks.

Study Overview

• Status: Completed
• Conditions: Chronic Disease
• Intervention / Treatment: Behavioral: Self management training

Detailed Description

Pre-assessments were taken from young adults who reported that they wanted to participate in the study via social media accounts and e-mail and who met the study criteria, and two groups were formed by simple randomization method. The study group received 8 weeks of self-management training. The control group was informed about self-management for 1 week. Final evaluations were conducted for both groups after eight weeks.

• Study Type: Interventional
• Enrollment (Actual): 72
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Turkey
  • Ankara, Turkey
    • Saglik Bilimleri Universitesi

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• having no communication barriers
• having a chronic disease such as asthma, diabetes, heart disease, or hypertension

Exclusion Criteria:

• being under 35 years old
• undergoing concurrent psychological treatment/therapy
• having Covid-19
• requiring treatment for other diseases during the training process

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Supportive Care
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Intervention Group; The study group received 8 weeks of self-management training. Reflections, prepared using Power Point, were used in all sessions. The study employed various methods, including the question-answer and audio-visual methods, as well as performance feedback when necessary during the sessions. Final evaluations were conducted for both groups after eight weeks.	Behavioral: Self management training; The self-management training programme for the study group consisted of eight sessions. Each session lasted between 40 and 50 minutes and followed a structured format: a 5-minute introduction, a 5-minute summary of the previous session, and a 30-40 minute presentation on the session's topic. Training plan on cognition, emotion regulation and self-management was implemented
Active Comparator: Control Group; The control group was informed about self-management for 1 week. General information was given about approaches to improving self-management. Final evaluations were conducted for both groups after eight weeks.	Behavioral: Self management training; The self-management training programme for the study group consisted of eight sessions. Each session lasted between 40 and 50 minutes and followed a structured format: a 5-minute introduction, a 5-minute summary of the previous session, and a 30-40 minute presentation on the session's topic. Training plan on cognition, emotion regulation and self-management was implemented

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Self-Control Self-Management Scale (SCMS)	The Self-Control and Self-Management Scale consists of three subscales: self-monitoring, self-evaluation and self-reinforcement. It is a 6-point Likert-type scale consisting of 16 items (0= Does not define me at all, 5= Defines me completely).	pre-treatment and post-treatment up to 8-weeks

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Cognitive Emotion Regulation Questionnaire (CERQ)	The five-point Likert-type scale (1 = not at all suitable for me, 2 = somewhat suitable for me, 3 = partially suitable for me, 4 = very suitable for me, 5 = completely suitable for me) consists of a total of 36 items. It consists of nine sub-dimensions: self-blame, acceptance, rumination, positive refocusing, refocus on planning, positive reappraisal, putting into perspective, catastrophizing, and other-blame.	pre-treatment and post-treatment up to 8-weeks
The Occupational Balance Questionnaire (OBQ)	In 2019, Günal et al. conducted a validity and reliability study of the 11-item revised version of the questionnaire in Turkish. The scale consists of four response categories (strongly disagree, disagree, agree, strongly agree), with each item being assigned a value between 0 and 3 points. The sum of the individual items results in a score between 0 and 33.	pre-treatment and post-treatment up to 8-weeks

Collaborators and Investigators

• Sponsor: Saglik Bilimleri Universitesi
• Investigators: Principal Investigator: Esma Ozkan, Saglik Bilimleri Universitesi

Study record dates

Study Major Dates

• Study Start (Actual): April 15, 2021
• Primary Completion (Actual): April 15, 2021
• Study Completion (Actual): August 15, 2021

Study Registration Dates

• First Submitted: February 22, 2024
• First Submitted That Met QC Criteria: March 6, 2024
• First Posted (Actual): March 7, 2024

Study Record Updates

• Last Update Posted (Actual): March 7, 2024
• Last Update Submitted That Met QC Criteria: March 6, 2024
• Last Verified: February 1, 2024

More Information

Terms related to this study

• Keywords: Self-Management; Young Adults; Chronic Conditions
• Additional Relevant MeSH Terms: Pathologic Processes; Disease Attributes; Chronic Disease
• Other Study ID Numbers: 2021-157

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No